Results 21 to 30 of about 62,480 (248)

Sjögren Sendromu ve Şizofreni komorbiditesi

open access: yesAnkara Medical Journal, 2015
Sjogren Sendromu toplumda % 2-3 oranında görülen kronik otoimmün bir hastalıktır. Santral sinir sistemi tutulumu olan Sjogren Sendromunda psikiyatrik ve nörolojik bulguların varlığı bildirilmiştir.OLGU. 35 yaşında kadın hasta, insanların kendisi hakkında
Serdar Can   +3 more
doaj   +1 more source

Health-related quality of life and depression among participants in the Sjögren's International Collaborative Clinical Alliance registry. [PDF]

open access: yes, 2017
ObjectiveTo examine health-related quality of life (HRQoL) and depression among participants in an international Sjögren's syndrome (SS) registry, comparing those with and without SS.MethodsCross-sectional study of participants in the Sjögren's ...
Chou, Annie   +5 more
core   +1 more source

A 41-year-old Female Presenting with Sicca Syndrome

open access: yesPhilippine Journal of Otolaryngology Head and Neck Surgery, 2008
Objective: To describe a case of Sicca syndrome, review the literature on and discuss the diagnostic criteria for Sjögren Syndrome. Methods: Design: Case report Setting: Private Clinic  Patients: One Results: A 41-year-old female ...
Laurence Ian Tan   +1 more
doaj   +1 more source

Primary Sjögren′s syndrome without ocular involvement: A rare case report

open access: yesJournal of Indian Academy of Oral Medicine and Radiology, 2014
Sjögren′s Syndrome (SS) is a chronic systemic autoimmune disorder, characterized by the lymphocytic infiltration of lacrimal and salivary glands, giving rise to dry eyes (keratoconjunctivitis sicca) and dry mouth (xerostomia).
Tushar Phulambrikar   +3 more
doaj   +1 more source

Testosterone Influence on Gene Expression in Lacrimal Glands of Mouse Models of Sjögren Syndrome [PDF]

open access: yes, 2019
Purpose: Sjögren syndrome is an autoimmune disorder that occurs almost exclusively in women and is associated with extensive inflammation in lacrimal tissue, an immune-mediated destruction and/or dysfunction of glandular epithelial cells, and a ...
Kam, Wendy R.   +6 more
core   +2 more sources

Cerebrospinal Fluid Tau, p-Tau 181 and Amyloid-beta(38/40/42) in Frontotemporal Dementias and Primary Progressive Aphasias [PDF]

open access: yes, 2010
Background/Aims: We determined cerebrospinal fluid (CSF) concentrations of amyloid-beta(A beta)(1-38), A beta(1-40), A beta(1-42), total tau and phospho-tau (p-tau) in order to study their differential expression in frontotemporal dementia (FTD, n = 25 ...
Bibl, Mirko   +8 more
core   +1 more source

Primary Sjögren syndrome: report of a 10 years old girl with local edema and positivity of anti SS-A and anti SS-B autoantibodies

open access: yesReumatismo, 2011
Sjögren-Larsson syndrome (SLS) is an autoimmune disease, uncommon in childhood. We report a case of SLS in a 10-year-old girl with a history of tumor, calor and rubor in the back of her toes almost every month, which resolved in 4-5 days without therapy.
V. Gerloni   +4 more
doaj   +1 more source

Livedoid Vasculitis in a Patient With Sjogren Syndrome Successfully Treated With Methotrexate

open access: yesClinical Medicine Insights: Case Reports, 2022
Introduction: Cutaneous vasculitis occurs in a sizable minority of patients with Sjogren syndrome. In addition, their response to different modalities of therapy is variable.
Abdulkarim Yousef Aldehaim   +1 more
doaj   +1 more source

Two new liverworts for Europe in Macaronesia : Odontoschisma prostratum (Sw.) Trevis. on the Azores and Jungermannia callithrix Lindenb. & Gottsche on the Azores and Madeira [PDF]

open access: yes, 1999
Odontoschisma prostratum (Sw.) Trevis. and Jungermannia callithrix Lindenb. et Gottsche, two liverworts mainly distributed in the Neotropics, are reported at hand of many collections from Macaronesia. O.
Schumacker, René, Váňa, Jiri
core  

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy